Skip to Main Content
Table 4—

Comparison of inflammatory and endothelial markers between case and control subjects

Case subjectsControl subjectsPr>|t|
Adiponectin (μg/ml) 4.3 (3.6–5.8) 5.3 (4.3–6.3) 0.01 
CRP (mg/l) 4.5 (2.5–8.3) 4.9 (2.1–8.6) 0.98 
IL-6 (pg/ml) 5.2 (3.3–6.2) 4.9 (4.0–6.2) 0.86 
TNF-α (pg/ml) 3.2 (2.4–5.2) 3.0 (2.4–4.1) 0.80 
sPLA2 (ng/ml) 3.0 (2.2–4.1) 3.3 (2.2–4.5) 0.72 
sE-selectin (ng/ml) 75 (66–94) 76 (59–94) 0.68 
sICAM-1 (ng/ml) 324 (263–364) 338 (298–385) 0.40 
sVCAM-1 (ng/ml) 499 (413–550) 490 (444–562) 0.26 
vWF (%) 92 (65–128) 106 (80–132) 0.17 
Case subjectsControl subjectsPr>|t|
Adiponectin (μg/ml) 4.3 (3.6–5.8) 5.3 (4.3–6.3) 0.01 
CRP (mg/l) 4.5 (2.5–8.3) 4.9 (2.1–8.6) 0.98 
IL-6 (pg/ml) 5.2 (3.3–6.2) 4.9 (4.0–6.2) 0.86 
TNF-α (pg/ml) 3.2 (2.4–5.2) 3.0 (2.4–4.1) 0.80 
sPLA2 (ng/ml) 3.0 (2.2–4.1) 3.3 (2.2–4.5) 0.72 
sE-selectin (ng/ml) 75 (66–94) 76 (59–94) 0.68 
sICAM-1 (ng/ml) 324 (263–364) 338 (298–385) 0.40 
sVCAM-1 (ng/ml) 499 (413–550) 490 (444–562) 0.26 
vWF (%) 92 (65–128) 106 (80–132) 0.17 

Data are median ± interquartile range. Calculations are from 70 case-control subject pairs for adiponectin and from 68 case-control subject pairs for all other markers except IL-6, which was calculated for 66 case-control subject pairs.

Close Modal

or Create an Account

Close Modal
Close Modal